Biomatics Capital Partners

Biomatics Capital Partners is a Seattle-based healthcare and life sciences venture firm. Biomatics is a $200 million fund that focuses on early-stage investments, primarily in genomics and digital health. We are at a tipping point. The convergence of genomics and digital data is enabling the development of superior therapeutics, diagnostics, and delivery models. Breakthrough science is transforming medicine into a value-based healthcare system, leading to lower costs and better patient outcomes. Biomatics helps create the next generation of companies that will lead this transformation.